David W. Nassif
CIK 1636975 · CFO / CLO · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.91M
Companies
4
Total Filings
16
Lifetime Open-Market Net
-$402.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHVS | CFO / CLO | 120,300 | $32.48 | $3.91M | -$303.1K | 1 | 2026-05-26 |
| Sio Gene Therapies Inc. (SIOX) Delisted | Interim CEO, CFO | 51,538 | $0.48 | $24.6K | $0 | 4 | 2022-02-10 |
| Sio Gene Therapies Inc. (AXGT) Delisted | Principal Financial Officer | 18,944 | — | — | $0 | 4 | 2020-06-15 |
| SteadyMed Ltd. (STDY) Delisted | EVP and CFO | 22,157 | — | — | -$99.7K | 5 | 2018-07-09 |
Recent Filings · Page 2 of 2
16 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-04 | — | Mixed | −22,157 | -$98.8K | |
| 2018-07-09 | SteadyMed Ltd. (STDY) Delisted | Sell (S) | −12,157 | -$54.7K | EDGAR |
| 2018-07-03 | SteadyMed Ltd. (STDY) Delisted | Sell (S) | −10,001 | -$45.0K | EDGAR |
| 2017-12-28 | SteadyMed Ltd. (STDY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-15 | SteadyMed Ltd. (STDY) Delisted | Grant (A) | +44,315 | $0 | EDGAR |
| 2016-07-22 | SteadyMed Ltd. (STDY) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–16 of 16
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.